Alerts will be sent to your verified email
Verify EmailVENMAX
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Venmax Drugs and Pharmaceuticals Limited engages in the manufacture and sale of bulk drugs intermediates primarily in India. It primarily offers trityl chloride. The company, formerly known as Yenkey Drugs and Pharmaceuticals Limited, was incorporated in 1988 and is based in Hyderabad, India.
Venmax Drugs&Pharma major competitors are Starsource Multitrad, Zenith Health Care, Ishita Drugs & Inds., Cian Healthcare, Hamps Bio, Saroja Pharma Ind, Phaarmasia. 
Market Cap of Venmax Drugs&Pharma is ₹21 Crs. 
While the median market cap of its peers are ₹21 Crs.
Venmax Drugs&Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.